本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ReShape Lifesciences, Inc.

0.3946
+0.01142.97%
盘后0.3925-0.0021-0.53%19:59 EDT
成交量:1,003.23万
成交额:408.08万
市值:444.96万
市盈率:-0.03
高:0.4360
开:0.3943
低:0.3700
收:0.3832
数据加载中...
2021/07/19

重要事件披露

8-K - Current report
2021/07/02

重要事件披露

8-K - Current report
2021/06/30

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/30

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/25

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/06/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/06/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/06/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/06/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/06/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/06/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/06/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/15

重要事件披露

8-K - Current report
2021/06/15

重要事件披露

8-K - Current report
2021/06/15

重要事件披露

8-K - Current report
2021/05/26

重要事件披露

8-K - Current report
2021/05/21

企业合并公告

425 - Prospectuses and communications, business combinations
2021/05/21

重要事件披露

8-K - Current report